Emraclidine
N/A
Report date: 2026/05/15 20:01:45
NME
Base Information
Drug NameEmraclidine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCerevel Therapeutics LlcPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesCerevel Therapeutics LlcAbbvie Inc
Inactive CompaniesN/A
Active Indications +[4]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksKEGG